Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVERROES: Apixaban vs ASA in Atrial Fibrillation
NCT00496769Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2007
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 36
01
Overview
A Phase 3 trial of apixaban in Atrial fibrillation (AFib), sponsored by Bristol Myers Squibb. Started Aug 2007; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00496769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496769.